4.1 Article

3β-Hydroxysteroid Dehydrogenase Type 2 (3βHSD2) Deficiency due to a Novel Compound Heterozygosity of a Missense Mutation (p.Thr259Met) and Frameshift Deletion (p.Lys273ArgFs*7) in an Undervirilized Infant Male with Salt Wasting

Related references

Note: Only part of the references are listed.
Article Cell Biology

Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population

Meshael M. Alswailem et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene

Ayla Guven et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2017)

Article Endocrinology & Metabolism

Carboxyl-terminal mutations in 3 beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia

Maik Welzel et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Article Endocrinology & Metabolism

Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3β-hydroxysteroid dehydrogenase deficiency

TH Johannsen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)